logo

For the Inventor, By the Inventor

Stevenage, United Kingdom

Nerre Therapeutics Limited


USPTO Granted Patents = 9



Forward Citations = 20

Loading Chart...
Loading Chart...

15 inventors (with patents filed for the assignee):

goldMedal Mike Trower (4 out of 9 patents)

silverMedal Giuseppe Alvaro (3 out of 58 patents)

bronzeMedal Agostino Marasco (3 out of 28 patents)

4.  Ronnie Maxwell Lawrence (1 out of 16 patents)

5.  Mary Kerr (1 out of 6 patents)

6.  Emiliangelo Ratti (1 out of 1 patent)

7.  Michael Trower (1 out of 1 patent)

8.  Andrew Simon Craig (1 out of 1 patent)

9.  Salima Zarah Ismail (1 out of 1 patent)

10.  Emiliano Castiglioni (1 out of 3 patents)

11.  Stephen Pawsey (1 out of 1 patent)

12.  Alessandro Falchi (6 patents)

13.  Riccardo Giovannini (63 patents)

14.  Daniele Andreotti (17 patents)

15.  Romano Di Fabio (33 patents)


9 patents:

1. 11872222 - Uses (2024-01-16),
2. 10195205 - Uses of dual NK1/NK3 receptor antagonists for treating sex-hormone diseases (2019-02-05),
3. 9907795 - Method of treatment of chronic cough administering orvepitant in combination with other therapeutic agents (2018-03-06),
4. 9750739 - Orvepitant for chronic cough therapy (2017-09-05),
5. 9603849 - Uses of orvepitant (2017-03-28),
6. 9006271 - 5-[5-[2-(3,5-bis(trifluoromethyl)phenyl)-2-methylpropanomethylpropanoylmethylamino]-4-(4-fluoro-2-methylphenyl)]-2-pyridinyl-2-alkyl-prolinamide as NK1 receptor antagonists (2015-04-14),
7. 8822504 - 5-[5-[2-(3,5-bis(trifluoromethyl)phenyl)-2-methylpropanomethylpropanoylmethylamino]-4-(4-fluoro-2-methylphenyl)]-2-pyridinyl-2-alkyl-prolinamide as NK1 receptor antagonists (2014-09-02),
8. 8796269 - [object Object] (2014-08-05),
9. 8633214 - Spiro (piperidine-4,2'-pyrrolidine)-1-(3,5-trifluoromethylphenyl) methylcarboxamides as NK1 tachikynin receptor antagonists (2014-01-21),
Company Overview
Nerre Therapeutics Limited is a biopharmaceutical company focused on developing innovative therapies for neurological and psychiatric disorders. Our team is dedicated to advancing the field of neurology through cutting-edge research and drug development. With a strong pipeline of potential treatments, we aim to improve the lives of patients suffering from these debilitating conditions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

9 Patents

#5 in Stevenage

#1,902 in United Kingdom

Stevenage, GB
Stevenage, United Kingdom

Nerre Therapeutics Limited

Forward Citations = 20

15 inventors:

goldMedal Mike Trower (4 out of 9 patents)

silverMedal Giuseppe Alvaro (3 out of 58 patents)

bronzeMedal Agostino Marasco (3 out of 28 patents)

4.  Ronnie Maxwell Lawrence (1 out of 16 patents)

5.  Mary Kerr (1 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nerre Therapeutics Limited. Retrieved from https://idiyas.com/company/nerre-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…